斯芬戈脂在安福特素B药物耐药性中的新兴作用
Kashish Madaan1, Vinay Kumar Bari1
1Department of Biochemistry, School of Basic Sciences, Central University of Punjab, Bathinda, India.
概括
侵袭性真菌感染中的安福特素B耐药性是一个越来越令人担忧的问题. 本综述强调了脂蛋白如何影响抗真菌药物耐药性,提供了新的治疗点.
科学领域:
- 菌类学 菌类学是指菌类学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 侵入性真菌感染构成重大威胁,特别是对免疫功能低下的个体,往往导致高死亡率.
- 氨酸B (AmB) 是一种关键的抗真菌剂,但耐药性,虽然不常见,但可能来自于厄戈斯特醇或细胞壁组成的改变.
- 菌 (Candida albicans) 和其他真菌可以对AMB产生抗药机制,从而影响治疗的有效性.
结论:
- 脂管道是新型抗真菌策略的有希望的目标,可以对抗安福特素B的耐药性.
- 对脂调节剂的进一步研究可能会导致开发辅助疗法,以提高AMB的疗效.
- 向由脂介导的耐药机制可能提供一种方法来恢复对现有的抗真菌药物的敏感性.
相关概念视频
Asymmetric Lipid Bilayer
7.3K
Biological membranes show uneven distribution of different types of lipids in the inner and outer layers, resulting in transverse asymmetric membranes. The treatment of the erythrocyte membrane with the enzyme phospholipase confirmed the asymmetric nature of the lipid bilayer. The enzyme hydrolyzes lipids into fatty acids and hydrophilic groups. The phospholipase acts only on the outer layer of the membrane, while the inner layer remains intact. The phospholipase treatment resulted in 80%...
7.3K
Development of Antibiotic Resistance
48
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
48
Biosynthesis of Lipids
41
Microbial membranes exhibit remarkable diversity in lipid composition, reflecting evolutionary adaptations to various environmental conditions. The three domains of life—Bacteria, Archaea, and Eukarya—synthesize membrane lipids through distinct biosynthetic pathways, leading to fundamental structural differences that impact membrane stability, function, and adaptability.Fatty Acid-Based Lipids in Bacteria and EukaryaBacteria and eukaryotes share a common fatty acid biosynthesis...
41
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Defense Against Bacterial Pathogens
1.5K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.5K
Drug Biotransformation: Overview
2.5K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.5K


